The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
Spring­Works Ther­a­peu­tics, a biotech po­ten­tial­ly on the verge of be­ing ac­quired, won its sec­ond FDA ap­proval. Get ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
At long last, the FDA approved Supernus Pharmaceuticals’ Parkinson’s disease treatment, which will be marketed as Onapgo.
The recall affects 12-ounce bags of the product, which were sold in 20 states and pose serious health risks if consumed.
A federal judge has told government agencies to restore public access to health-related webpages and datasets they removed to ...
theorizing that a different trial design could yield better results and pave the way for FDA approval in chronic pain. AP video journalist Mary Conlon contributed to this story from New York.
theorizing that a different trial design could yield better results and pave the way for FDA approval in chronic pain. AP video journalist Mary Conlon contributed to this story from New York.